KEY MARKET INSIGHTS
Listen to Audio Version
The global sickle cell disease treatment market size was estimated at USD 3.94 billion in 2025 and is projected to reach USD 4.73 billion in 2026 to USD 20.47 billion by 2034, growing at a CAGR of 20.10% from 2026 to 2034. United States dominated the sickle cell disease treatment market with a market share of 63.35% in 2025.
Sickle Cell Disease (SCD) is an inherited disorder causing diseases, such as hemoglobin sickle cell disease, hemoglobin SS disease, sickle cell anemia, and others causing deformation of red blood cells. This leads to early death of cells, causing blood shortage, and also inhibits blood flow, causing blockage. The treatment procedure includes blood transfusions, medication, and bone marrow transplants.
The global sickle cell disease treatment market growth is attributed to the increasing prevalence of SCD, rising awareness regarding the disease, and increasing focus of the key players on launching new effective drugs for sickle cell disease treatment.
Source: https://www.fortunebusinessinsights.com/industry-reports/sickle-cell-disease-treatment-market-101009